Literature DB >> 3281831

Expression, renaturation and purification of recombinant human interleukin 4 from Escherichia coli.

A van Kimmenade1, M W Bond, J H Schumacher, C Laquoi, R A Kastelein.   

Abstract

The lymphokine human interleukin 4 (IL-4) has been expressed from a plasmid in the cytoplasm of Escherichia coli. Advantage has been taken of insolubility of the human IL-4 in E. coli for rapid purification of this protein in only a few steps. We describe extraction and renaturation procedures which solubilize human IL-4 yielding biologically active protein. The protein was purified to homogeneity by one passage over a gel-filtration column. The refolded human IL-4 was characterized by N-terminal sequence analysis, amino acid analysis and bioassays. The refolded E. coli-derived human IL-4 has biological activity on T and B cells and binds to the human IL-4 receptor, comparable to mammalian expressed human IL-4, indicating that the protein is folded correctly.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3281831     DOI: 10.1111/j.1432-1033.1988.tb13973.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  Purification and characterization of recombinant human interleukin 4. Biological activities, receptor binding and the generation of monoclonal antibodies.

Authors:  R Solari; D Quint; H Obray; A McNamee; E Bolton; P Hissey; B Champion; E Zanders; A Chaplin; B Coomber
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

2.  Complete 1H, 15N and 13C assignments, secondary structure, and topology of recombinant human interleukin-6.

Authors:  G Y Xu; J Hong; T McDonagh; M Stahl; L E Kay; J Seehra; D A Cumming
Journal:  J Biomol NMR       Date:  1996-09       Impact factor: 2.835

3.  Solubilization and renaturation of overexpressed aggregates of mutant tryptophan synthase alpha-subunits.

Authors:  W K Lim; H E Smith-Somerville; J K Hardman
Journal:  Appl Environ Microbiol       Date:  1989-05       Impact factor: 4.792

4.  Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function.

Authors:  A N McKenzie; J A Culpepper; R de Waal Malefyt; F Brière; J Punnonen; G Aversa; A Sato; W Dang; B G Cocks; S Menon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

5.  Tuberculosis-induced variant IL-4 mRNA encodes a cytokine functioning as growth factor for (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-specific Vgamma2Vdelta2 T cells.

Authors:  ZhuQing Yuan; Richard Wang; Yuyang Lee; Crystal Y Chen; XingBing Yu; ZhongDao Wu; Dan Huang; Ling Shen; Zheng W Chen
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

6.  Lack of effects of recombinant human interleukin-4 on in vitro colony formation of freshly explanted human tumor cells.

Authors:  A R Hanauske; D Degen; M H Marshall; P P Trotta; D D Von Hoff
Journal:  Invest New Drugs       Date:  1992-11       Impact factor: 3.850

7.  Cytoplasmic and periplasmic expression of a highly basic protein, human interleukin 4, in Escherichia coli.

Authors:  D Lundell; R Greenberg; Y Alroy; R Condon; J D Fossetta; K Gewain; R Kastelein; C A Lunn; R Reim; C Shah
Journal:  J Ind Microbiol       Date:  1990-06

8.  Cloning, expression and functional characterization of in-house prepared human basic fibroblast growth factor.

Authors:  Hassan Rassouli; Mohammad Sharif Tabe Bordbar; Mehran Rezaei Larijani; Mohammad Pakzad; Hossein Baharvand; Ghasem Hosseini Salekdeh
Journal:  Cell J       Date:  2013-02-20       Impact factor: 2.479

9.  Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction.

Authors:  S M Zurawski; F Vega; B Huyghe; G Zurawski
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

10.  Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells.

Authors:  V Brinkmann; T Geiger; S Alkan; C H Heusser
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.